The Supreme Court has temporarily reinstated an FDA rule permitting mifepristone to be dispensed and mailed to patients, pausing a lower court ruling that had restricted access to the abortion medication. The move keeps the status quo in place while legal challenges proceed through the courts. The decision drew significant coverage across the political spectrum, with outlets differing sharply on its implications.
Danco Laboratories, the manufacturer of mifepristone, has asked the Supreme Court to restore mail-order access to the abortion pill after an appeals court blocked the FDA policy allowing it to be prescribed via telehealth and delivered by mail. The case returns the abortion drug to the nation's highest court following years of ongoing legal battles over access to one of the most commonly used methods for ending a pregnancy in the United States.
A federal appeals court has ruled that mifepristone, the most commonly used abortion medication in the United States, cannot be sent through the mail, with the ruling carrying nationwide effect. The decision restricts a telehealth prescription model that expanded significantly during and after the COVID-19 pandemic. The ruling is expected to face further legal challenges.
The Supreme Court ruled unanimously that anti-abortion pregnancy centers have legal standing to challenge state subpoenas seeking their donor records on First Amendment grounds. The decision allows the centers to contest government demands for donor information before being compelled to comply. The ruling has implications for donor privacy and state investigative authority over nonprofit organizations.
The Justice Department has fired multiple prosecutors who brought cases under the Freedom of Access to Clinic Entrances (FACE) Act against anti-abortion activists during the Biden administration. The dismissals are part of a broader effort by the current DOJ to reverse prosecutorial decisions it views as politically motivated. The move comes alongside related actions to vacate seditious conspiracy convictions stemming from January 6.
Planned Parenthood of Illinois agreed to pay $500,000 to settle a U.S. Equal Employment Opportunity Commission investigation finding the affiliate violated Title VII by segregating employees by race in mandatory affinity caucuses and making derogatory statements toward white employees in DEI training sessions. NPR confirmed the settlement; conservative outlets including The Daily Wire framed it as validation of the Trump EEOC's aggressive anti-DEI enforcement strategy.
A new Missouri poll shows that a November 2026 ballot measure — Amendment 3 — that would overturn the state's 2024 voter-approved abortion rights amendment and simultaneously ban gender transition procedures for minors currently leads 47-40 percent. KCUR/NPR and Fox 2 St. Louis both confirmed the poll; critics say the two issues are bundled to leverage high opposition to trans care into support for an abortion ban that most Missourians otherwise oppose.
Wyoming's only abortion clinic — Wellspring Health Access in Casper — began turning patients away in the days after Gov. Mark Gordon signed the Human Heartbeat Act on March 9, with Wyoming Public Media reporting that about a dozen patients were turned away in the law's first week. The clinic has challenged the ban in court and continues to offer services to patients before the six-week threshold. LifeNews celebrated the law as "already saving babies;" left-leaning outlets focused on the lack of rape and incest exceptions.
Missouri Sen. Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, a bill that would strip FDA approval from mifepristone — used in 63 percent of U.S. abortions — and enable women to sue manufacturers. Fox News covered the bill favorably; NPR-affiliated stations and medical groups say the drug is backed by decades of safety data and that Hawley's cited research lacks peer review. Notably, the White House and Senate Republican leadership have not endorsed the bill.
The Trump administration's HHS Office for Civil Rights opened investigations into 13 predominantly Democratic states on March 19, alleging their laws requiring insurance plans to cover abortion violate the Weldon Amendment — a federal conscience protection law that prohibits discrimination against providers that decline to cover abortion. The Hill and the Washington Examiner both confirmed the investigations, which give states 20 days to respond or face potential loss of federal funding.
Sen. Josh Hawley introduced the 'Safeguarding Women from Chemical Abortion Act' on March 11, 2026, which would revoke FDA approval of mifepristone and allow women to sue its manufacturer. A House companion bill was introduced simultaneously. Fox News and NPR confirmed the same legislative details — the drug's 63% market share and the bill's introduction — while framing it as either necessary safety reform or unscientific political interference.
CBS, Wyoming Public Media, Fox News, and the ACLU all confirm two contrasting abortion developments: Wyoming enacted a ~6-week ban while an Indiana court blocked its ban for violating religious freedom.
Florida voters passed Amendment 4 with 57.3% of the vote on November 5, 2024 — but the measure needed 60% to amend the state constitution. Both Fox News and NPR confirmed the same vote tally, agreeing that Florida's six-week abortion ban remains in effect despite majority support for the amendment.
Arizona voters passed Proposition 139 — enshrining abortion access until fetal viability in the state constitution — with 61.6% of the vote on November 5, 2024. Both Fox News and NPR confirmed the same tally, noting that Arizona's legislature had already repealed the state's 1864 near-total abortion ban in April 2024.
Louisiana became the first state to criminalize the possession of mifepristone and misoprostol when obtained for an illegal abortion, with penalties up to five years in prison. Fox News and NPR both confirmed the law's enactment and scope, though they framed it as either a milestone in protecting life or an unprecedented intrusion into healthcare.
The Supreme Court voted 9-0 on June 13, 2024, to dismiss the challenge to the FDA's approval of mifepristone, ruling that anti-abortion doctors lacked legal standing to sue. Both Fox News and NPR confirmed the unanimous ruling, though they diverged on whether the narrow holding was a victory or a temporary reprieve.
NPR, AP, and Fox News agreed that the Supreme Court unanimously rejected the challenge to the FDA's mifepristone rules on standing grounds. The split was over whether the ruling settled the issue or only postponed the next abortion-pill fight.
AP, Fox News, and CBS News agreed that Louisiana became the first state to place mifepristone and misoprostol on a controlled-dangerous-substances schedule. The split was over whether the law protects patients from coercion or further restricts reproductive care.
AP, Reuters, and Fox News agreed that Arizona lawmakers voted to repeal the state's 1864 near-total abortion ban after intense public and political backlash. The disagreement was over whether the repeal was a narrow political retreat or a broader public rebuke of strict abortion bans.
NPR, CNN, and Fox News agreed that Florida's Supreme Court let a six-week abortion ban take effect while also allowing an abortion-rights amendment onto the ballot. The split was over whether the ruling marked a pro-life policy victory or a warning sign for Republicans heading into the election.
